Newsfeeds - Spark Newswire

1 minute read

HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Lowers Price Target to $26

Today, 11:58 PM

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price target from $27 to $26.

CRBU

1 minute read

Caribou Biosciences Q4 EPS $(0.44) Beats $(0.46) Estimate, Sales $3.69M Beat $3.07M Estimate

By Michael Horton

Today, 11:58 PM

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.46) by 4.35 percent. This is a 41.94 percent decrease over losses of $(0.31) per share

CRBU

3 minute read

Caribou Biosciences Presents Case Report On Long-Term Follow Up Of First Patient Dosed In Phase 1 ANTLER Trial At The Lymphoma, Leukemia, & Myeloma Congress 2022 October 18-22

By Benzinga Newsdesk

Today, 11:58 PM

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the presentation of a case report for long-term follow up on the first patient

CRBU

1 minute read

Valneva, Take-Two Interactive And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session

By Lisa Levin

Today, 11:58 PM

U.S. stock futures traded lower this morning after recording losses last week. Here are some big stocks moving lower in today’s pre-market trading session.

ATHX